ARTICLE | Company News
Momenta, Shire deal
October 3, 2016 7:00 AM UTC
Momenta said Shire gave a 12-month notice to terminate a 2011 deal granting Shire development and commercialization rights to M923, a biosimilar of Humira adalimumab. Shire gained rights to the cand...